Efficacy and safety of baricitinib in combination with topical corticosteroids in patients with moderate‐to‐severe atopic dermatitis with inadequate response, intolerance or contra... von Bieber, Thomas, Reich, Kristian, Paul, Carle, Tsunemi, Yuichiro, Augustin, Matthias, Lacour, Jean‐Philippe, Ghislain, Pierre‐Dominique, Dutronc, Yves, Liao, Ran, Yang, Fan E., Brinker, Dennis, DeLozier, Amy M., Meskimen, Eric, Janes, Jonathan M., Eyerich, Kilian

Volltext

Efficacy and safety of lebrikizumab in moderate-to-severe atopic dermatitis: 52-week results of two randomized double-blinded placebo-controlled phase III trials von Blauvelt, Andrew, Thyssen, Jacob P, Guttman-Yassky, Emma, Bieber, Thomas, Serra-Baldrich, Esther, Simpson, Eric, Rosmarin, David, Elmaraghy, Hany, Meskimen, Eric, Natalie, Chitra R, Liu, Zhuqing, Xu, Chenjia, Pierce, Evangeline, Morgan-Cox, MaryAnn, Garcia Gil, Esther, Silverberg, Jonathan I

Volltext

42136 Lebrikizumab improvement in itch reduction at 52 weeks in patients with moderate-to-severe atopic dermatitis: pooled analysis of two phase 3 randomized controlled trials von Yosipovitch, Gil, Lio, Peter, Rosmarin, David, Legat, Franz, Carrascosa, Jose Manuel, Meskimen, Eric, Casillas, Marta, Pierce, Evangeline, Liu, Zhuqing, Zhong, Jinglin, Ständer, Sonja

Volltext

41916 Lebrikizumab reduced interference of itch on sleep at 52 weeks in patients with moderate-to- severe atopic dermatitis: pooled analysis of two phase 3 randomized controlled tr... von Yosipovitch, Gil, Lio, Peter A., Rosmarin, David, Legat, Franz J., Carrascosa, Jose-Manuel, Meskimen, Eric, Casillas, Marta, Pierce, Evangeline, Xu, Chenjia, Zhong, Jinglin

Volltext

493 - Lebrikizumab does not impact vaccine-induced immune responses: results from a phase 3 study in adult patients with moderate-to-severe atopic dermatitis von Soung, Jennifer, Laquer, Vivian, Merola, Joseph F, Forman, Seth, Elmaraghy, Hany, Meskimen, Eric, Hu, Chaoran, Natalie, Chitra R, Pierce, Evangeline, Torisu-Itakura, Hitoe, Gil, Esther Garcia, Jarell, Abel D

Volltext

322 Efficacy and safety of lebrikizumab in moderate-to-severe atopic dermatitis: 52-week results of two randomized, double-blinded, placebo-controlled phase 3 trials (ADvocate1 and... von Blauvelt, Andrew, Thyssen, Jacob P, Guttman-Yassky, Emma , Bieber, Thomas, Carrascosa, Jose Manuel, Simpson, Eric, Rosmarin, David , Elmaraghy, Hany, Meskimen, Eric, Natalie, Chitra R, Liu, Zhuqing, Xu, Chenjia, Pierce, Evangeline, Morgan-Cox, MaryAnn, Silverberg, Jonathan I

Volltext

373 Safety of lebrikizumab in adults and adolescents with moderate-to-severe atopic dermatitis: data from eight trials von Gold, Linda Stein, Thaçi, Diamant, Thyssen, Jacob P  , Gooderham, Melinda, Laquer, Vivian , Natalie, Chitra R, Zhao, Fangyi , Meskimen, Eric, ElMaraghy, Hany, Montmayeur, Sonia , Jimenez, Gemma, de Bruin-Weller, Marjolein

Volltext

Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: An Integrated Analysis of Eight Clinical Trials von Stein Gold, Linda, Thaçi, Diamant, Thyssen, Jacob P., Gooderham, Melinda, Laquer, Vivian, Moore, Angela, Natalie, Chitra R., Zhao, Fangyi, Meskimen, Eric, Elmaraghy, Hany, Montmayeur, Sonia, Gallo, Gaia, Jimenez, Gemma, de Bruin-Weller, Marjolein

Volltext

Safety of lebrikizumab in adults and adolescents with moderate-to-severe atopic dermatitis: an integrated analysis of eight clinical trials von Adis Journals on behalf of, Stein Gold, Linda, Thaçi, Diamant, P. Thyssen, Jacob, Gooderham, Melinda, Laquer, Vivian, Moore, Angela, Natalie, Chitra R., Zhao, Fangyi, Meskimen, Eric, Elmaraghy, Hany, Montmayeur, Sonia, Gallo, Gaia, Jimenez, Gemma, de Bruin-Weller, Marjolein

Volltext bestellen

Efficacy and Safety of Baricitinib in Combination With Topical Corticosteroids in Patients With Moderate-to-Severe Atopic Dermatitis With Inadequate Response, Intolerance, or Contr... von Bieber, Thomas, Reich, Kristian, Paul, Carle, Tsunemi, Yuichiro, Augustin, Matthias, Lacour, Jean-Philippe, Ghislain, Pierre-Dominique, Dutronc, Yves, Liao, Ran, Yang, Fan E, Brinker, Dennis, DeLozier, Amy M, Meskimen, Eric, Janes, Jonathan M, Eyerich, Killian

Volltext

IL-13 ANTIBODIES FOR THE TREATMENT OF ATOPIC DERMATITIS von PILLAI, Sreekumar, RUEDA, Maria Jose, MESKIMEN, Eric R, ATWATER, Amber

Volltext bestellen

Efficacy and safety of lebrikizumab in moderate-to-severe atopic dermatitis : 52-week results of two randomized double-blinded placebo-controlled phase III trials von Blauvelt, Andrew, Thyssen, Jacob Pontoppidan, Guttman-Yassky, Emma, Bieber, Thomas, Serra-Baldrich, E, Simpson, Eric L, Rosmarin, David M, Elmaraghy, Hany, Meskimen, Eric, Natalie, Chitra R, Liu, Zhuqing, Xu, Chenjia, Pierce, Evangeline J, Morgan-Cox, Mary Ann, García-Gil, Esther, Silverberg, Jonathan, Universitat Autònoma de Barcelona

Volltext bestellen